Ignite Creation Date:
2024-05-06 @ 3:35 PM
Last Modification Date:
2024-10-26 @ 1:52 PM
Study NCT ID:
NCT04683445
Status:
UNKNOWN
Last Update Posted:
2020-12-24
First Post:
2020-12-19
Brief Title:
Efficacy and Safety of Eribulin in the Treatment of Advanced Breast Cancer
Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Organization Data
Organization:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Class:
OTHER
Study ID:
2020-KY-064
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Lead Sponsor Class:
OTHER
Responsible Party:
Ying Wang
Responsible Party Title:
associate chief physician
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Old Name:
None
Old Organization:
None